公开(公告)号：US20240041953A1

公开(公告)日：2024-02-08

申请号：US18194313

申请日：2023-03-31

Applicant: DUPONT NUTRITION BIOSCIENCES APS

Inventor： Lotta Stenman ,  Sampo Lahtinen ,  John Konhilas

IPC: A61K35/747 ,  A23L33/135 ,  A61K35/74 ,  A61P9/10

CPC classification number: A61K35/747 ,  A23L33/135 ,  A61K35/74 ,  A61P9/10 ,  A23V2002/00 ,  A23V2400/181 ,  A23V2200/326

Abstract: The use of a bacterium of the species Lactobacillus salivarius in the manufacture of a food product, dietary supplement or medicament for treating cardiac dysfunction, particularly myocardial infarction, congestive heart failure, dilated cardiomyopathy or inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis) is disclosed.

公开(公告)号：US20210346439A1

公开(公告)日：2021-11-11

申请号：US16916425

申请日：2020-06-30

Applicant: DUPONT NUTRITION BIOSCIENCES APS

Inventor： Lotta Stenman ,  Sampo Lahtinen ,  John Konhilas

IPC: A61K35/747 ,  A23L33/135 ,  A61K35/74 ,  A61P9/10

Abstract: The use of a bacterium of the species Lactobacillus salivarius in the manufacture of a food product, dietary supplement or medicament for treating cardiac dysfunction, particularly myocardial infarction, congestive heart failure, dilated cardiomyopathy or inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis) is disclosed.

公开(公告)号：US10471110B2

公开(公告)日：2019-11-12

申请号：US15744211

申请日：2016-07-07

Applicant: DUPONT NUTRITION BIOSCIENCES APS

Inventor： Lotta Stenman ,  Sampo Lahtinen ,  John Konhilas

IPC: A61K35/745 ,  A23L33/135 ,  A61P9/00 ,  A61K35/74

Abstract: This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction, dilated cardiomyopathy, inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis), and congestive heart failure.

公开(公告)号：US20180207210A1

公开(公告)日：2018-07-26

申请号：US15744252

申请日：2016-07-07

Applicant: DUPONT NUTRITION BIOSCIENCES APS

Inventor： Lotta Stenman ,  Sampo Lahtinen ,  John Konhilas

IPC: A61K35/747 ,  A23L33/135 ,  A61P9/10

CPC classification number: A61K35/747 ,  A23L33/135 ,  A23V2002/00 ,  A23V2200/326 ,  A23Y2220/79 ,  A61K35/74 ,  A61P9/10

Abstract: The use of a bacterium of the species Lactobacillus salivarius in the manufacture of a food product, dietary supplement or medicament for treating cardiac dysfunction, particularly myocardial infarction, congestive heart failure, dilated cardiomyopathy or inflammatory heart disease (including endocarditis, inflammatory cardiomegaly and myocarditis) is disclosed.